Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Katrina A. Brewer"'
Autor:
Donald F. Stec, Alice L. Rodriguez, Ryan D. Morrison, Anna L. Blobaum, Roger Rush, Daryl F. Venable, Katrina A. Brewer, Andrew S. Felts, Thomas M. Bridges, P. Jeffrey Conn, Kyle A. Emmitte, Craig W. Lindsley, Melany M. Corlew, Colleen M. Niswender, Tammy S. Santomango, Frank W. Byers, J. Scott Daniels, Raymundo Sanchez-Ponce, Carrie K. Jones, Brittney S. Bates, Jason Manka
Negative allosteric modulation (NAM) of metabotropic glutamate receptor subtype 5 (mGlu5) represents a therapeutic strategy for the treatment of childhood developmental disorders, such as fragile X syndrome and autism. VU0409106 emerged as a lead com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0389e68c022ccf3e9d93be7fbdaf65
https://europepmc.org/articles/PMC3422546/
https://europepmc.org/articles/PMC3422546/
Autor:
Min Li, Zixiu Xiang, Bende Zou, Ryan D. Morrison, L. Michelle Lewis, Carrie K. Jones, Debbie Mi, Owen B. McManus, Bruce J. Melancon, Corey R. Hopkins, Liya Yang, J. Scott Daniels, Haibo Yu, Frank W. Byers, John T. Brogan, Jonathan S. Aldrich, Tammy S. Santomango, Eric S. Dawson, Michael L. Schulte, Craig W. Lindsley, C. David Weaver, Ximin Simon Xie, P. Jeffrey Conn, Katrina A. Brewer, Analisa D. Thompson
T-type Ca(2+) channel inhibitors hold tremendous therapeutic potential for the treatment of pain, epilepsy, sleep disorders, essential tremor and other neurological disorders; however, a lack of truly selective tools has hindered basic research, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36641cbd013156ef42cf09d64e40e063
https://europepmc.org/articles/PMC3285241/
https://europepmc.org/articles/PMC3285241/